SS Innovations International Expands Surgical Robotics Reach with 224 Systems Installed Across 12 Countries

SS Innovations International (NASDAQ: SSII) is gaining momentum in the surgical robotics market, driven by growing adoption of its SSi Mantra system and a push into new regulatory territories. The company recently announced that more than 50 robotic procedures were performed in a single day at Mohak Bariatrics and Robotics in Indore, India, underscoring the system's efficiency and reliability in high-volume clinical settings. With 224 SSi Mantra systems installed across 12 countries and a 143% year-over-year increase in robotic procedures during the second quarter of 2026, the company is demonstrating strong commercial traction.

Quarterly revenue rose 39% to $13.9 million, while system sales increased 41% to $12.4 million. Installations reached 30 systems during the quarter, reflecting expanding demand for cost-effective robotic surgery solutions. India remains the primary commercial market, but SS Innovations is actively pursuing regulatory approvals in Europe and the United States. CE marking is targeted for the end of 2026, and FDA review of its 510(k) application is now expected by the end of the first quarter of 2027. These milestones could open significant new revenue streams and position the company to compete in the global surgical robotics arena.

The company is also developing telesurgery capabilities and expanding surgeon training programs to drive utilization and adoption. By making robotic surgery more affordable and accessible, SS Innovations aims to address a critical gap in healthcare delivery, particularly in underserved regions. This focus on affordability and accessibility could disrupt the traditional surgical robotics market, where high costs have limited adoption. For investors, the company's growth trajectory and regulatory progress present a compelling opportunity in the medtech sector.

TechMediaWire, a specialized communications platform focused on pioneering technology companies, has highlighted SS Innovations through its network. TechMediaWire is part of the Dynamic Brand Portfolio at IBN, which provides access to wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, and social media distribution to millions of followers. These corporate communications solutions help companies like SS Innovations reach a broad audience of investors and industry stakeholders.

For more details on SS Innovations' progress, the full article is available at https://ibn.fm/6FPBS. As the company advances toward CE marking and FDA review, its success could catalyze broader adoption of robotic surgery worldwide, with implications for healthcare providers, patients, and investors. The growing utilization in India and planned expansions into Europe and the U.S. signal a potential shift in the surgical robotics landscape, making SS Innovations a company to watch.